cagrisema novo nordisk

News

Novo Nordisk Cuts Guidance

Novo Nordisk shares jump 7% as drugmaker sees copycat Wegovy sales easing in 2025

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

NBC Los Angeles · 23h

Novo Nordisk cuts 2025 guidance as drug copycats hit Wegovy sales, posts first-quarter profit beat

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Financial Times · 17h

Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up

Wegovy maker expects second-half rise in business that used to go to pharmacies’ custom-made ‘compounded’ versions

Novo Nordisk Q1 Earnings Match Estimates

Seeking Alpha · 18h

Novo Nordisk Q1 2025: One Of The Best Deals You Can Get Right Now

Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO stock remains a strong buy for me.

MarketWatch · 8h

Health Care Up After Novo Nordisk Earnings -- Health Care Roundup

Novo Nordisk shares rose after the Danish obesity-drug maker's first-quarter earnings topped Wall Street expectations. As widely anticipated, the drug maker reduced its growth forecast to reflect the appearance of copycat versions of its blockbuster weight-loss and diabetes drugs in the U.

SFGate · 20h

Novo Nordisk: Q1 Earnings Snapshot

The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 92 cents per share. The drugmaker posted revenue of $11.01 billion in the period, which missed Street forecasts.

The Economist10h

Eli Lilly looks set to steal Novo Nordisk’s weight-loss crown

Investors are betting that Lilly will maintain its momentum. Its share price has climbed by a third since the start of 2024; ...

Morningstar6d

Novo Nordisk Shares Jump After Wegovy Deal With CVS

However, the stock is down more than 50% over the past 12 months as the company faced a number of setbacks with its developmental weight-loss drug, CagriSema. Novo Nordisk in March released trial ...

13don MSN

Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending

Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025

Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results